Therapeutic implications of mitochondrial stress–induced proteasome inhibitor resistance in multiple myeloma | Zendy

Aditi Sharma | Zendy; Remya Nair | Zendy; Abhinav Achreja | Zendy; Anjali Mittal | Zendy; Pulkit Gupta | Zendy; Kamakshi Balakrishnan | Zendy; Claudia L. Edgar | Zendy; Olamide Animasahun | Zendy; Bhakti Dwivedi | Zendy; Benjamin G. Barwick | Zendy; Vikas A. Gupta | Zendy; Shan M. Matulis | Zendy; Manoj Bhasin | Zendy; Sagar Lonial | Zendy; Ajay K. Nooka | Zendy; Arun P. Wiita | Zendy; Lawrence Boise | Zendy; Deepak Nagrath | Zendy; Mala Shanmugam | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Therapeutic implications of mitochondrial stress–induced proteasome inhibitor resistance in multiple myeloma

Author(s) -

Aditi Sharma,

Remya Nair,

Abhinav Achreja,

Anjali Mittal,

Pulkit Gupta,

Kamakshi Balakrishnan,

Claudia L. Edgar,

Olamide Animasahun,

Bhakti Dwivedi,

Benjamin G. Barwick,

Vikas A. Gupta,

Shan M. Matulis,

Manoj Bhasin,

Sagar Lonial,

Ajay K. Nooka,

Arun P. Wiita,

Lawrence Boise,

Deepak Nagrath,

Mala Shanmugam

Publication year - 2022

Publication title -

science advances

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 5.928

H-Index - 146

ISSN - 2375-2548

DOI - 10.1126/sciadv.abq5575

Subject(s) - venetoclax , multiple myeloma , proteasome , mitochondrion , gene expression , translation (biology) , proteasome inhibitor , integrated stress response , glutathione , microbiology and biotechnology , cancer research , biology , chemistry , gene , biochemistry , messenger rna , genetics , immunology , enzyme , leukemia , chronic lymphocytic leukemia

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research